A detailed history of Royal Bank Of Canada transactions in Personalis, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 77,476 shares of PSNL stock, worth $380,407. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77,476
Previous 75,891 2.09%
Holding current value
$380,407
Previous $88,000 372.73%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.19 - $6.34 $1,886 - $10,048
1,585 Added 2.09%
77,476 $416,000
Q1 2024

May 15, 2024

SELL
$1.15 - $2.19 $21,045 - $40,077
-18,300 Reduced 19.43%
75,891 $113,000
Q4 2023

Feb 14, 2024

BUY
$0.93 - $2.35 $17,019 - $43,005
18,300 Added 24.11%
94,191 $197,000
Q3 2023

Nov 14, 2023

SELL
$1.19 - $2.36 $22,529 - $44,679
-18,932 Reduced 19.97%
75,891 $91,000
Q2 2023

Aug 14, 2023

BUY
$1.8 - $3.19 $34,077 - $60,393
18,932 Added 24.95%
94,823 $178,000
Q1 2023

May 15, 2023

SELL
$2.01 - $4.17 $3,451 - $7,159
-1,717 Reduced 2.21%
75,891 $209,000
Q4 2022

Feb 14, 2023

BUY
$1.78 - $3.64 $3,050 - $6,238
1,714 Added 2.26%
77,608 $153,000
Q3 2022

Nov 14, 2022

SELL
$2.89 - $5.32 $664 - $1,223
-230 Reduced 0.3%
75,894 $225,000
Q2 2022

Aug 15, 2022

SELL
$3.27 - $8.76 $6,853 - $18,360
-2,096 Reduced 2.68%
76,124 $262,000
Q1 2022

May 16, 2022

SELL
$7.56 - $14.3 $45,564 - $86,186
-6,027 Reduced 7.15%
78,220 $641,000
Q4 2021

Feb 14, 2022

BUY
$12.24 - $21.25 $41,628 - $72,271
3,401 Added 4.21%
84,247 $1.2 Million
Q3 2021

Nov 15, 2021

SELL
$16.69 - $26.05 $33,596 - $52,438
-2,013 Reduced 2.43%
80,846 $1.56 Million
Q2 2021

Aug 16, 2021

BUY
$18.15 - $27.75 $1.5 Million - $2.3 Million
82,859 New
82,859 $2.1 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $225M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.